ORDER
BLUMENFELD, District Judge.This declaratory judgment action is now almost two years old. Its history is one of almost continuous application by counsel to this court for resolution of the innumerable disputes which have arisen in the course of preparation of the case for trial. The present difficulty before the court is Broadview’s dissatisfaction with the pace at which Loctite is evaluating Broadview’s anaerobic sealant compositions, which are the subject matter of the suit, to determine whether or not they infringe Loetite’s patents. Loctite has had samples of Broadview’s compositions for several months, during which time it has presented the court with a variety of reasons for its failure to date to complete the tests necessary for infringement evaluation.
On March 2, 1971, the court ordered Loctite to begin submitting weekly reports on the progress of its evaluation. Since then, Loctite has submitted one report covering the months of January and February 1971 and another for the first two weeks in March. In the first report, Loctite estimates that its tests on the first series of Broadview formu-lae (the KBK series) will not be completed before June 4, 1971.
Loctite enjoys a dominant position in the anaerobic sealant market. Obviously, each day’s delay in evaluating Broad-view’s compositions inures to the benefit of Loctite and the detriment of Broadview. Loctite’s responses to inquiries into the reasons for the delay appear to the court to be in large part dilatorily motivated. Accordingly, the court considers it now appropriate to *354fashion relief in favor of the Broadview to protect it against the consequences of Loctite’s further delay.
Broadview has suggested a number of avenues of relief. Its latest suggestion is that the injunction entered against it on May 10, 1969, by this court be suspended until the court decides the infringement issues presented by this case. The injunction restrained Broad-view and those in active concert with it from infringing three of Loctite’s patents and from selling or using specific compositions whose sale and use had already been found to have violated the terms of a prior consent decree between the parties. See Broadview Chem. Corp. v. Loctite Corp., 406 F.2d 538 (2d Cir.), cert. denied, 394 U.S. 976, 89 S.Ct. 1472, 22 L.Ed.2d 755 (1969).
The court does not view wholesale suspension of the injunction as a suitable remedy. Loctite’s dilatoriness at this stage of the proceedings does not mitigate Broadview’s earlier conduct which resulted in a finding of civil contempt and an extensive award of damages in addition to the injunction sought to be suspended. Nevertheless, some of the sting can be taken out of the injunction order without destroying its efficacy. The order now provides for a penalty of $2,000.00 for each violation of the injunction or consent decree. Eliminating the “in terrorem effect,” Broadview Chem. Corp. v. Loctite Corp., 417 F.2d 998, 1001 (2d Cir. 1969), cert. denied, 397 U.S. 1064, 90 S.Ct. 1502, 25 L.Ed.2d 686 (1970), of the penalty provision may make it less risky for Broadview to begin the manufacture and sale of compositions which in its judgment do not infringe and may give Loctite additional incentive to quickly complete its infringement evaluation. Of course, if Broadview is wrong about the nonin-fringement of its compositions, it might still be subject, in the appropriate case, to sanctions for violation of the injunction.
Accordingly, it is the order of the court that the penalty provision of the injunction entered in this case on May 10, 1969, be, and hereby is, suspended until resolution by this court of the infringement issues raised by this declaratory judgment action. The court will continue to be concerned with Loctite’s progress toward infringement evaluation and will entertain further applications for relief if that progress should be unsatisfactory.
So ordered.